[Federal Register: August 2, 1999 (Volume 64, Number 147)] [Notices] [Page 41936] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr02au99-107] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Meeting of the Advisory Committee on Blood Safety and Availability AGENCY: Office of the Secretary. ACTION: Notice of meeting. ----------------------------------------------------------------------- The Advisory Committee on Blood Safety and Availability will meet on August 26, 1999, from 9:00 a.m. to 5:00 p.m. and on August 27, 1999 from 9:00 a.m. to 3:00 p.m. The meeting will take place in the Ticonderoga Room of the Hyatt Regency Hotel on Capitol Hill, 400 New Jersey, NW., Washington, DC 20001. The meeting will be entirely open to the public. On the morning of August 26, the Committee will consider responses to the deferral of certain former United Kingdom residents from blood donation. That afternoon, the Committee will consider the current availability of blood products, and the current status of the hepatitis C lookback effort. On August 27, the Committee will consider the issue of how federally mandated blood safety initiatives should be financed. Public comment will be solicited on these topics both days. Public comment will be limited to five minutes per speaker. Those who wish to have printed material distributed to Advisory Committee members should submit thirty (30) copies to the Executive Secretary prior to close of business August 13, 1999. FOR FURTHER INFORMATION CONTACT: Stephen D. Nightingdale, M.D., Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Safety, Department of Health and Human Services, 200 Independence Avenue SW, Washington, DC 20201. Phone (202) 690-5560 FAX (202) 690-6584 e-mail STEPHENDNIGHTINGALE @osophs.dhhs.gov. Dated: July 15, 1999. Stephen D. Nightingale, Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. 99-19643 Filed 7-30-99; 8:45 am] BILLING CODE 4160-17-M